Shandong Xinhua Pharmaceutical Company Limited, a joint stock company incorporated in the People’s Republic of China, recently published an updated version of its Articles of Association. The document details the Company’s registered name, legal address, shareholding structure, corporate governance framework, and rules on shareholder and board operations.

Key points include:

The total number of issued ordinary shares is stated to be 682,407,635. The Articles outline multiple historical share issuances and exercises of share options that impacted the Company’s share capital. It further specifies requirements for changes in registered capital, such as repurchase of shares, and addresses the process for shareholders who object to certain major corporate actions to request the Company to purchase their shares at a fair price.

The document explains the organizational structure of the Company’s governance, including a board of directors comprised of nine members, with four serving as independent non-executive directors. It also describes the duties of the chairman (who represents the Company in its affairs), the general manager, and the secretary to the board of directors. Additional provisions cover the formation of specialized committees under the board of directors—namely the Strategic Development Committee, the Audit Committee, the Remuneration and Appraisal Committee, and the Nomination Committee—along with their respective functions and powers.

Guidelines for profit distribution are discussed, noting that shareholders must approve profit allocations, and that certain reserves must be maintained or used to address losses. The Articles also outline procedures for calling and conducting shareholders’ meetings, directors’ meetings, and the obligations of directors and senior management to act in the best interests of the Company.

Lastly, the Articles address circumstances and procedures for corporate restructuring, such as merger, demerger, and liquidation, as well as safeguards to protect creditor and shareholder interests. The revised Articles of Association took effect upon approval by the shareholders’ general meeting and are subject to relevant government registration and disclosure requirements.